Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.
Bazett M, Costa AM, Bosiljcic M, Anderson RM, Alexander MP, Wong SWY, Dhanji S, Chen JM, Pankovich J, Lam S, Sutcliffe S, Gunn H, Kalyan S, Mullins DW.
Bazett M, et al. Among authors: dhanji s.
Oncoimmunology. 2017 Nov 27;7(3):e1398875. doi: 10.1080/2162402X.2017.1398875. eCollection 2018.
Oncoimmunology. 2017.
PMID: 29399400
Free PMC article.